Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.
about
Virus-encoded superantigensGenetics of neoplasia--impact of ecogenetics on oncogenesis. A review.Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritisDefective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies.T cell cytotoxicity to Epstein-Barr virus infected B cells: comparison of patients with rheumatoid arthritis and their HLA identical siblings.Antiviral cell-mediated immune responses and effect of chromosome polymorphism in Herpesvirus saimiri-infected monkeys.Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis.Rheumatoid arthritis--a virus disease?Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.Functional characterization of infiltrating T lymphocytes in human hepatic allografts.Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lSuppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosisAbnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritisEpstein-Barr virus membrane antigens: characterization, distribution, and strain differences.Autoimmune diseases: immunopathology and etiopathogenesisDimer-size DNA circles in a leukemic cell immortalized with the Epstein-Barr virus.In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.Establishment of long-term monocyte suspension cultures from normal human peripheral bloodAnalysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation.Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome.An Epstein-Barr virus-associated superantigenMonoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivityImmune regulation in Epstein-Barr virus-associated diseasesNegative modulation of Epstein-Barr virus episomes by a human B-cell growth factor.Abrogation of simian virus 40 DNA-mediated transformation of primary C57BL/6 mouse embryo fibroblasts by exposure to a simian virus 40-specific cytotoxic T-lymphocyte clone.Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo.Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades.Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virusPrevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.Decreased oxygen radical generation by neutrophils from patients with measles presumably owing to activation of suppressor T lymphocytes.Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein.A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.Lymphocyte subpopulations in man: suppression of PWM-induced B-cell proliferation by infectious mononucleosis T cells.
P2860
Q28776748-4F7B63D8-7AD4-4BD4-A03B-1CCE9FFA6920Q30500345-B50AD7DC-9495-44C2-AED3-F36450E06024Q33556764-E5C7978B-46C3-4C8C-8ECB-58B785E08538Q33556770-197E5D92-228E-4374-BB3B-39E7C41FC441Q33557056-99857D2B-8D0C-47B9-917D-0B7D87D8515BQ33560806-1DF7124C-E926-4D24-8CCF-BD4A884FB47DQ33899614-6CD5AF28-4AE8-4E9A-A333-32614259B237Q34262343-28049C09-A2D0-458B-B758-E2CD13B0C410Q34302702-AE4092A2-BC80-4A44-BD54-4E9FDD2AB952Q34334755-B0DE46CE-E399-4E81-8214-546E03753F09Q34420983-4F13DA94-C8F1-45CF-B59B-B3BBDFBA213DQ34533784-470B3F72-B173-4359-93E1-6D03647CC573Q34553140-4E5AC99F-F89B-4BDC-8971-991A156D91CBQ35209798-1A4F7DC2-5B84-4CA3-A2F0-388D440A829EQ35239753-684F7AD3-A81B-4F4B-8CD2-53749C8DF2FAQ35885043-685A6651-313F-4E90-B587-F6B9B5DC40BBQ36306923-194259E1-296D-4C3A-937D-3DFC8DE39AAEQ36342050-4C6B265C-7340-4584-97A6-61FE8E8B70DAQ36343938-6AD46019-F34E-43CC-AA5D-A9AB64828280Q36346568-9D743247-A11D-472B-8312-4EB6ABA8E5FCQ36347266-9180FCE0-911C-4268-8849-57975DD47096Q36349693-B4EA04FA-D8E4-4FEC-A040-0678EABC3FC0Q36356442-A9062B7F-FF62-4DF4-9F30-27B695C0A934Q36367270-D1C18F7A-519A-4CEF-A7E6-B06532040662Q36406027-BD512279-0766-4CE3-84D0-CED65F662A23Q36669953-58EA2A03-F043-482E-BC1E-A00CC3787824Q36829599-833BB756-4790-4292-A4AB-CA672BEC67E3Q36852680-4B07A179-B888-4EB6-A88B-E2B6215174B7Q36901884-2751EBCE-A27A-4911-BF86-A6E6BFCC3042Q36904686-A48D816C-4E1B-444D-9D95-423317CAB9EEQ36923500-33E2601A-3247-407F-9CB5-E4AC02938526Q36987928-5DDD8976-9C92-4BF6-A2EF-17D84EDC612AQ36988786-57FF1A21-AAB3-4672-A6C6-F4A0E1F71234Q37001473-4FC278AF-1379-4F81-9E12-0A3B71D83A12Q37097273-BFE7FAB5-417C-495A-A5E8-D8A611DBE1D4Q37277265-F58A0215-C353-45E7-A779-F2B1A9989757Q37410691-CF2BF77E-60E6-457E-8995-FCFE56418975Q37997650-CC3EBDC5-7061-49F5-8581-F3A38F999C2FQ39781753-5BC92500-F52E-452F-82A2-647F2669251FQ39905662-55BC7B19-841D-4B9B-8134-C7D1BCD95EA3
P2860
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@ast
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@en
type
label
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@ast
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@en
prefLabel
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@ast
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@en
P2860
P356
P1476
Suppression of in vitro Epstei ...... for adult human T lymphocytes.
@en
P2093
Thorley-Lawson DA
P2860
P304
P356
10.1084/JEM.146.2.495
P407
P577
1977-08-01T00:00:00Z